BERNASCONI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 8.755
AS - Asia 7.074
EU - Europa 5.428
SA - Sud America 860
AF - Africa 140
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.275
Nazione #
US - Stati Uniti d'America 8.578
CN - Cina 3.795
SG - Singapore 1.494
UA - Ucraina 1.021
IE - Irlanda 982
HK - Hong Kong 726
DE - Germania 662
BR - Brasile 657
FI - Finlandia 604
IT - Italia 529
VN - Vietnam 481
RU - Federazione Russa 440
SE - Svezia 440
FR - Francia 326
GB - Regno Unito 237
BD - Bangladesh 104
IN - India 104
CA - Canada 92
AR - Argentina 74
IQ - Iraq 56
JP - Giappone 56
MX - Messico 56
ZA - Sudafrica 49
NL - Olanda 45
ID - Indonesia 35
PK - Pakistan 34
TR - Turchia 33
PL - Polonia 28
CO - Colombia 26
VE - Venezuela 26
EC - Ecuador 25
ES - Italia 25
SA - Arabia Saudita 24
PH - Filippine 22
MA - Marocco 21
BE - Belgio 18
PY - Paraguay 18
AT - Austria 16
TN - Tunisia 16
UZ - Uzbekistan 15
MY - Malesia 13
AU - Australia 11
CL - Cile 11
JO - Giordania 11
KE - Kenya 11
AZ - Azerbaigian 9
PA - Panama 9
RO - Romania 9
IR - Iran 8
BO - Bolivia 7
DZ - Algeria 7
IL - Israele 7
LT - Lituania 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
OM - Oman 6
PE - Perù 6
EG - Egitto 5
ET - Etiopia 5
EU - Europa 5
HN - Honduras 5
KR - Corea 5
KZ - Kazakistan 5
AL - Albania 4
AO - Angola 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
LV - Lettonia 4
MD - Moldavia 4
MU - Mauritius 4
PS - Palestinian Territory 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
GR - Grecia 3
KG - Kirghizistan 3
NP - Nepal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
MZ - Mozambico 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
Totale 22.255
Città #
Jacksonville 1.242
Chandler 1.073
Dublin 982
Nanjing 951
San Jose 907
Ashburn 724
Hong Kong 711
Singapore 685
Dallas 521
Boardman 436
Nanchang 413
Beijing 361
Shenyang 270
Princeton 261
Lawrence 260
Changsha 255
Hebei 254
Wilmington 228
Lauterbourg 221
Jiaxing 206
New York 189
Los Angeles 186
Medford 179
Ho Chi Minh City 153
Tianjin 153
Hangzhou 143
Hanoi 137
Ann Arbor 109
Buffalo 109
Milan 108
Redondo Beach 94
Helsinki 82
Moscow 79
Council Bluffs 77
Shanghai 56
São Paulo 56
Tokyo 51
Woodbridge 51
Norwalk 48
Munich 45
Orem 44
Toronto 44
Verona 39
Santa Clara 37
Frankfurt am Main 34
Seattle 34
Johannesburg 29
Turku 29
Des Moines 28
Jinan 28
Zhengzhou 28
Rome 26
Baghdad 25
Da Nang 25
London 24
Chicago 23
Fairfield 23
Houston 23
Pavia 23
Warsaw 23
Brooklyn 22
Montreal 22
Kunming 21
San Francisco 21
Guangzhou 20
Rio de Janeiro 20
Brussels 18
Haiphong 18
Ningbo 18
Denver 17
Mexico City 17
Belo Horizonte 16
Nuremberg 16
Atlanta 15
Tashkent 15
The Dalles 15
Amsterdam 14
Chennai 13
Falkenstein 13
Guayaquil 13
Curitiba 12
Falls Church 12
Lanzhou 12
Taizhou 12
Washington 12
Biên Hòa 11
Dhaka 11
Phoenix 11
Stockholm 11
Amman 10
Columbus 10
Fuzhou 10
New Delhi 10
Pune 10
Auburn Hills 9
Baku 9
Bologna 9
Lahore 9
Manchester 9
Nairobi 9
Totale 14.207
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 188
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 163
FISH vantaggi e svantaggi 157
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma 150
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 147
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 145
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma 144
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 143
[Multiple myeloma localized in the superior maxillary. Description of an uncommon case]. 141
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 139
Blast phase of essential thrombocythemia: A single center study. 138
Alcaloidi della vinca e dell'epipodofillotossina 137
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 134
Alterazioni del cariotipo nelle sindromi mielodisplastiche: significato patologico e clinico 133
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 130
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 128
Acute myeloid leukemia and diabetes insipidus: results in five patients 124
Acute nonlymphocytic leukemia : evidence of clonogenic cells in perypheral blood early in complete remission 122
Etoposide : il citostatico della linea monocitica 120
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 120
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 119
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 118
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 118
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 117
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 116
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 116
La citogenetica e la biologia molecolare nella valutazione del chimerismo e della malattia minima residua 116
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 115
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 114
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 113
ABL1 amplification in T-cell acute lymphoblastic leukemia. 112
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution. 111
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 109
Iperplasia gengivale da Ciclosporina-A nel paziente emopatico: considerazioni cliniche 109
Alterazioni citogenetiche nelle leucemie linfatiche croniche 109
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 109
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 105
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 105
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 103
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 103
A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia. 103
Infusione di linfociti del donatore nella recidiva dopo tapianto di midollo osseo allogenico 102
Il controllo odontostomatologico nel paziente affetto da emopatia maligna: studio preliminare 102
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 102
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 101
Central nervous system relapse in acute promyelocytic leucemia 100
Growth factors in the therapy of myelodisplasia: biological aspects. 100
Evolving approaches with alpha interferon in chronic myelogenous leukemia 100
Fattori di crescita emopoietici (G-CSF e GM-CSF) nel trapianto di midollo osseo allogenico 100
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma 100
Alternative Splicing of hTERT: a further Mechanism for the Control of Active hTERT in Acute Myeloid Leukaemia 100
Additional chromosomal abnormalities in Ph positive clone: adverse prognostic influence on frontline imatinib therapy, a GIMEMA WP on CML analysis. 100
Impiego della citosina a basse dosi: risultati global 99
Valutazione prognostica dele sindromi mielodisplastiche 98
Alterazioni citogenetiche nelle leucemie acute 98
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation 98
Role of the molecular staging and response in the management of follicular lymphoma patients 97
Analisi citogenetica e molecolare in onco-ematologia: rilevanza per diagnosi, prognosi e scelte terapeutiche 96
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 96
Rischio infettivologico in pazienti affetti da leucemia acuta e sottoposti a trapianto di midollo osseo autologo. Studio di 14 casi 95
Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report 95
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 95
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 95
Storia naturale e trasformazione istologico/clinica dei linfomi a bassa malignita’. 94
Treatment of relapsed and refractory acute myloid leukemia in adults 94
Localizzazione di mieloma multiplo al mascellare superiore 94
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 93
Interessamento del cromosoma 3 nelle mielodisplasie (MDS) 93
Carateristiche cliniche peculiari delle leucemie acute monocitiche e loro rilievo prognostico 93
Telomero e telomerasi:biologia e osservazioni preliminari nelle neoplasie ematologiche 92
Importanza clinica della malattia minima residua nel post-trapianto” Progetto “Progressi in Biologia e Medicina 92
Autoimmunita’ nella malattia da trapianto contro l’ospite 92
Leucemia mielomonocitica cronica 92
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 92
Selezione delle cellule CD 34 positive. 92
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 91
Exercise intolerance at high altitude (5050 m): critical power and W'. 91
FuseFISH: Robust detection of transcribed gene fusions in single cells 91
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 90
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 90
Controllo delle infezioni nelle leucemie acute 90
Molecularly targeted therapy in acute myeloid leukemia. 89
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 89
L’ibridazione in situ per documentare il chimerismo e l’origine della recidiva nel trapianto allogenico di midollo osseo 89
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 89
Classificazione citogenetica delle LAM: impatto prognostico e terapeutico 88
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 88
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia—analysis of 848 patients 88
Significance of MLC for BMT with serological HLA-identical related and unrelated donors 88
Hematopoietic growth factors in bone marrow transplantation 86
Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study 86
Interferon-alfa plus low-dose cytosine arabinoside in advanced phase chronic myeologenus leukaemia patients. 86
Complicanze emorragiche e trombotiche nel paziente chirurgico 86
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 85
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 85
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 85
Trapianto di midollo osseo nelle sindromi mielodisplastiche e nelle leucemie acute evolute da sindrome mielodisplastica 85
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 85
Immunochemotherapy with rituximab, vincristine and 5-days cyclophosphamide (R-CV) for heavily pretreated follicular lymphoma 85
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. 84
Totale 10.614
Categoria #
all - tutte 92.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/20221.015 14 7 37 15 26 64 19 82 61 23 156 511
2022/20233.159 362 203 7 259 394 367 0 219 1.188 25 83 52
2023/20241.126 102 213 30 108 112 396 8 65 11 33 13 35
2024/20252.895 47 322 76 98 81 59 159 252 629 74 230 868
2025/20266.847 446 504 807 811 697 335 1.346 240 585 634 303 139
Totale 22.403